Type 2 Diabetes
Disease State Hub
Featured
04/16/2026
March 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...
04/16/2026
Nutrition411: The Podcast, Ep. 60
Nutrition411: The Podcast, Ep. 60
04/15/2026
Lisa Jones, MA, RDN, LDN, FAND; Bonnie Chambers, MSN, FNP-C
This episode of Nutrition411 explores how clinicians and dietitians can set realistic, emotionally informed expectations for patients using GLP-1 medications for obesity.
04/15/2026
04/02/2026
Anthony Calabro, MA
The FDA approved oral GLP-1 orforglipron (Foundayo) for weight management without food or water restrictions.
04/02/2026
Interactive Features
03/26/2026
Kate Young
Diabetes mellitus represents one of the most powerful and prevalent cardiometabolic risk factors facing U.S. adults today. Test your knowledge about diabetes prevalence.
03/26/2026
08/22/2025
Anthony Calabro, MA
Metabolic dysfunction–associated steatohepatitis is becoming increasingly common in patients with type 2 diabetes and other metabolic risk factors. Test your knowledge of the key diagnostic features,...
08/22/2025
07/24/2025
Diana Isaacs, PharmD, CDCES
With broader availability, adults with prediabetes and even those simply seeking health insights can now track glucose trends in real time—empowering earlier interventions, self-discovery, and more...
07/24/2025
04/15/2025
Anthony Calabro, MA
Missed a key conference this year? We've got you covered! This curated slideshow brings together the most compelling moments, expert takeaways, and practice-changing data from the medical conferences you...
04/15/2025
09/27/2024
There are “myths” that surround the use of GLP-1 receptor agonists among patients, and it is a health care provider’s role to help their patients understand the benefits and adverse effects of these...
09/27/2024
Clinical Insights
Nutrition411: The Podcast, Ep. 60
Nutrition411: The Podcast, Ep. 60
04/15/2026
Lisa Jones, MA, RDN, LDN, FAND; Bonnie Chambers, MSN, FNP-C
This episode of Nutrition411 explores how clinicians and dietitians can set realistic, emotionally informed expectations for patients using GLP-1 medications for obesity.
04/15/2026
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
02/10/2026
Mary Elizabeth Patti, MD
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
02/10/2026
07/30/2025
Diana Isaacs, PharmD, CDCES
The approval of new prescription-free glucose biosensors has significantly broadened access to continuous glucose monitoring (CGM) technology for various populations, including those with prediabetes and...
07/30/2025
ACP Internal Medicine Meeting 2025 Video Interview
ACP Internal Medicine Meeting 2025 Video Interview
04/15/2025
Irl Hirsch, MD, MACP
From GLP-1s to access deserts, Irl B. Hirsch, MD, MACP highlights key topics from his ACP Internal Medicine Meeting presentation on 2024's top endocrine studies and urgent care challenges.
04/15/2025
